Table 1.

Schedule of assessments for PRELUDE-1 study.

Study Assessments	Within 14 Days	SRT Start	40 Days after Last SRT	After Two Months	Every Three Months	Follow-up
Informed consent	X
Eligibility crietria	X
Pregnancy test	X			X	X	X
Concurrent medications	X			X	X	X
Cardiologic evaluation	X			X	X	X
Anamnesis	X			X	X	X
Height	X
Weight	X		X	X	X	X
Clinical examination, PS ECOG, vital signs	X		X	X	X	X
Blood count and clinical biochemistry, CEA, and CA19.9	X		X	X	X	X
Assessment of cytokines, regulatory cells, HLA haplotype determination	X		X
Total-body computed tomography with iv contrast	X		X	X	X	X
18F-fluoro-2-deoxy-D glucose-positron emission tomography scans	X		X
Liquid biopsy	X		X
Adverse events evaluation	X		X	X	X	X
Progression-free survival				X	X	X